Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13466
Country/Region: Uganda
Year: 2016
Main Partner: Uganda Protestant Medical Bureau
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $1,920,238 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $365,082
Care: Orphans and Vulnerable Children (HKID) $174,425
Care: TB/HIV (HVTB) $87,691
Care: Pediatric Care and Support (PDCS) $140,343
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $249,118
Sexual Prevention: Other Sexual Prevention (HVOP) $30,808
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $70,166
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $754,082
Treatment: Pediatric Treatment (PDTX) $48,523
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 32
GEND_GBV Age/Sex: <10 Male 2017 20
GEND_GBV Age/Sex: 10-14 Female 2017 94
GEND_GBV Age/Sex: 10-14 Male 2017 20
GEND_GBV Age/Sex: 15-19 Female 2017 167
GEND_GBV Age/Sex: 15-19 male 2017 38
GEND_GBV Age/Sex: 20-24 Female 2017 166
GEND_GBV Age/Sex: 20-24 Male 2017 32
GEND_GBV Age/Sex: 25-49 Female 2017 68
GEND_GBV Age/Sex: 25-49 Male 2017 32
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 63
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 146
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 523
GEND_GBV Number of people receiving post-GBV care 2017 669
GEND_GBV Sum of Age/Sex Disaggregates 2017 166
HTS_TST Age/sex: <1 2017 957
HTS_TST Age/sex: 1-9 2017 3,150
HTS_TST Age/sex: 10-14 Female 2017 2,719
HTS_TST Age/sex: 10-14 Male 2017 2,720
HTS_TST Age/sex: 15-19 Female 2017 9,640
HTS_TST Age/sex: 15-19 Male 2017 8,901
HTS_TST Age/sex: 20-24 Female 2017 14,459
HTS_TST Age/sex: 20-24 Male 2017 13,351
HTS_TST Age/sex: 25-49 Female 2017 22,171
HTS_TST Age/sex: 25-49 Male 2017 20,472
HTS_TST Age/sex: 50+ Female 2017 1,928
HTS_TST Age/sex: 50+ Male 2017 1,780
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,772
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,774
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 48,198
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 44,504
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 102,248
HTS_TST Service Delivery Point (Facility): Index testing 2017 7,886
HTS_TST Service Delivery Point (Facility): Inpatient 2017 22,449
HTS_TST Service Delivery Point (Facility): Other PITC 2017 6,818
HTS_TST Service Delivery Point (Facility): Outpatient 2017 43,502
HTS_TST Service Delivery Point (Facility): Pediatric 2017 9,053
HTS_TST Service Delivery Point (Facility): PMTCT 2017 11,768
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 772
HTS_TST Sum of Age/Sex disaggregates 2017 98,141
HTS_TST Sum of Aggregated Age/Sex <15 2017 9,546
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 92,702
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 102,248
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 105
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 109
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 362
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 255
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 542
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 382
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 832
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 584
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 71
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 50
HTS_TST_POS Test Result by Age: Positive: <1 2017 35
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 125
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 186
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 188
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,807
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,271
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 707
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 707
KP_PREV Total estimated number of key population in the catchment area 2017 1,412
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 1,412
OVC_SERV Age/Sex: 18+ Female 2017 407
OVC_SERV Age/Sex: 18+ Male 2017 337
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 1,163
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 1,088
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 2,995
OVC_SERV Sum of Age/Sex disaggregates 2017 744
PMTCT_ART Already on ART at beginning of current pregnancy 2017 358
PMTCT_ART New on ART 2017 243
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 11,937
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 396
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 105
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 5
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 19
PMTCT_EID Sum of Infant Age disaggregates 2017 501
PMTCT_STAT By: Known positives at entry 2017 371
PMTCT_STAT By: Number of new positives identified 2017 257
PMTCT_STAT Number of new ANC and L&D clients 2017 12,244
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 11,937
PMTCT_STAT Sum of Positives Status disaggregates 2017 628
PP_PREV Aggregated Age/sex: <15 Female 2017 457
PP_PREV Aggregated Age/sex: <15 Male 2017 422
PP_PREV Aggregated Age/sex: 15+ Female 2017 536
PP_PREV Aggregated Age/sex: 15+ Male 2017 540
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 1,955
PP_PREV Total number of people in the target population 2017 9,241
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 55
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 107
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 164
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 164
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,188
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 120
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 354
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 714
TB_SCREENDX Screen Result: Screened Positive for TB 2017 296
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 9,190
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 4,733
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 487
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 432
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 14,842
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 10
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 149
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 14
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 277
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 450
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 450
TX_CURR Age/Sex: <1 2017 38
TX_CURR Age/Sex: <1-9 2017 218
TX_CURR Age/Sex: 10-14 Female 2017 356
TX_CURR Age/Sex: 10-14 Male 2017 307
TX_CURR Age/Sex: 15-19 Female 2017 459
TX_CURR Age/Sex: 15-19 Male 2017 144
TX_CURR Age/Sex: 20-24 Female 2017 2,114
TX_CURR Age/Sex: 20-24 Male 2017 946
TX_CURR Age/Sex: 25-49 Female 2017 6,158
TX_CURR Age/Sex: 25-49 Male 2017 3,405
TX_CURR Age/Sex: 50+ Female 2017 459
TX_CURR Age/Sex: 50+ Male 2017 238
TX_CURR Aggregated Age/Sex: <15 Female 2017 487
TX_CURR Aggregated Age/Sex: <15 Male 2017 432
TX_CURR Aggregated Age/Sex: 15+ Female 2017 9,190
TX_CURR Aggregated Age/Sex: 15+ Male 2017 4,733
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 14,842
TX_CURR Sum of age/sex disaggregates 2017 603
TX_CURR Sum of Aggregated Age/Sex <15 2017 919
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 13,923
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 14,842
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 121
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 103
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,739
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 900
TX_NEW By Age/Sex: <1 2017 5
TX_NEW By Age/Sex: 1-9 2017 54
TX_NEW By Age/Sex: 10-14 Female 2017 91
TX_NEW By Age/Sex: 10-14 Male 2017 74
TX_NEW By Age/Sex: 15-19 Female 2017 87
TX_NEW By Age/Sex: 15-19 Male 2017 26
TX_NEW By Age/Sex: 20-24 Female 2017 402
TX_NEW By Age/Sex: 20-24 Male 2017 180
TX_NEW By Age/Sex: 25-49 Female 2017 1,164
TX_NEW By Age/Sex: 25-49 Male 2017 649
TX_NEW By Age/Sex: 50+ Female 2017 86
TX_NEW By Age/Sex: 50+ Male 2017 45
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,863
TX_NEW Sum of Age/Sex disaggregates 2017 2,804
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,863
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 11,874
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 10,687
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 349
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 311
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 6,617
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 3,410
TX_PVLS Numerator: Indication: Routine 2017 10,687
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 389
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 345
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 7,351
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 3,789
TX_PVLS_den Denominator: Indication: Routine 2017 11,874
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 43
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 41
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 51
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 188
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 544
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,232
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 37
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 418
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 51
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 59
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 810
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,711
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,631
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,957
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 29
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 44
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 49
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 46
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 57
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 209
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 384
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 612
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,385
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 45
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 96
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 56
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 67
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 912
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,922